Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CEL-SCI Q3 EPS $(0.23) Up From $(0.25) YoY

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.23) per share. This is a 8 percent increase over losses of $(0.25) per share from the same period last year.
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.23) per share. This is a 8 percent increase over losses of $(0.25) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

IBio Divesting CDMO Business and CGMP Biologics Manufacturing Facility, to Result in About 50% Annualized Cost Savings; Commenced Workforce Reduction of Approximately 60% of Current Company Staffing Levels

By Charles Gross
November 3, 8:09 AM
iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization (iBio CDMO, LLC) in order to complete its transformation into an antibody discovery and development company.

IBIO